Menu Search
Equities

NeuPath Health Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NPTH:CVE

NeuPath Health Inc

Actions
Health CareHealth Care Providers
  • Price (CAD)0.455
  • Today's Change-0.005 / -1.09%
  • Shares traded5.21k
  • 1 Year change+111.63%
  • Beta1.1282
Data delayed at least 15 minutes, as of Feb 10 2026 18:05 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

NeuPath Health Inc. operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging treatments and delivering patient-centered multidisciplinary care. It operates a network of medical clinics in Ontario and Alberta that provide comprehensive assessments and rehabilitation services to clients with chronic pain, musculoskeletal/back injuries, sports related injuries and concussions. It also provides workplace health services and independent medical assessments to employers and disability insurers through a national network of healthcare providers, as well as contract research services to pharmaceutical companies. The Company's health care providers cover a range of specialties and include physiatrists, neurologists, anesthesiologists, orthopedic surgeons, general practitioners with specialized training in chronic pain, as well as medication management physicians, athletic therapists, among others.

  • Revenue in CAD (TTM)83.93m
  • Net income in CAD-553.00k
  • Incorporated2019
  • Employees148.00
  • Location
    NeuPath Health Inc110 - 110 Matheson Blvd WestMISSISSAUGA L5R 4G7CanadaCAN
  • Phone+1 (647) 963-9319
  • Websitehttps://www.neupath.com/
More ▼

Institutional shareholders

11.34%Per cent of shares held by top holders
HolderShares% Held
Claret Asset Management Corp.as of 22 Apr 20256.17m11.34%
Data from 30 Sep 2025 - 30 Sep 2025Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.